share_log

MBX Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(9.48%),Deep Track Biotechnology Master Fund, Ltd.(9.48%), etc.

MBX Biosciences | SC 13G:超过5%持股股东披露文件-Deep Track Capital, LP(9.48%),Deep Track Biotechnology Master Fund, Ltd.(9.48%)等

美股SEC公告 ·  09/23 14:04
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息